传感器类型
综述或非传感器论文
检测对象
异丙肾上腺素(isoprenaline, ISO)诱导的PKA活性/cAMP信号与KATP电流;样品基质:培养血管平滑肌细胞(VSMCs)
检测原理
异丙肾上腺素(ISO)结合血管平滑肌细胞膜上的β-肾上腺素受体(β-AR,主要为β2-AR),通过Gs蛋白激活腺苷酸环化酶6(AC6),使细胞内cAMP水平升高并激活蛋白激酶A(PKA)。PKA活性变化被AKAR3 FRET生物传感器捕获:其FRET比率随PKA活性升高而改变,经440 nm激发、470/535 nm荧光强度比读出。同时,PKA磷酸化ATP敏感性钾通道(KATP)相关组分,增加K+外流,使膜电位超极化。siRNA敲低AC6会显著减弱cAMP、PKA和KATP电流响应,说明信号强度随AC6表达及ISO浓度变化。
检测灵敏度
原文未报告LOD、线性范围、灵敏度斜率或相关系数。
效应效果
AC6介导约60%的β-AR cAMP响应;AC6敲低使ISO诱导cAMP降至对照42%,AC3敲低降至70%,AC5无显著影响。AC6敲低使ISO增强的KATP电流降低74%,AC3/5/6共同敲低降低约95%。β-AR刺激使膜电位由-35.1±1.4 mV超极化至-62.5±3.3 mV,格列本脲逆转至-22.0±1.5 mV;ISO使格列本脲敏感电流增加13.2±2.8 pA/pF,PKA抑制剂KT5720阻断。作者认为AC6是血管舒张与血压调控关键组分。
传感器的构成
- 样品基质/细胞层:培养血管平滑肌细胞(VSMCs),提供β-AR、AC6、KATP通道与AKAR3表达环境
- 修饰/处理层:siRNA转染,选择性敲低AC3/AC5/AC6以解析同工酶功能
- 识别/报告元件:AKAR3 PKA活性FRET生物传感器,响应PKA活性变化
- 对照元件:AKAR3 T/A阴性对照,排除非特异性FRET变化
- 换能器/读出平台:Zeiss Axiovert 200荧光显微镜,440 nm激发并采集470/535 nm荧光
- 信号读出参数:FRET比率(470/535 nm荧光强度比),反映PKA活性变化
中文摘要
膜电位是决定血管张力的关键因素,多种血管舒张剂通过调节离子通道电流发挥作用。血管平滑肌细胞表达多种腺苷酸环化酶(AC)同工酶,但其在血管舒张信号中的功能冗余机制不明。本研究通过选择性短干扰RNA(siRNA)转染培养血管平滑肌细胞,使AC3、AC5和AC6表达降低超过75%,并检测β-肾上腺素受体(β-AR)刺激后的cAMP积累、蛋白激酶A(PKA)活性及ATP敏感性钾通道(KATP)电流。结果显示,AC6是介导β-AR诱导cAMP积累的主要同工酶,约占β-AR总反应的60%;AC3作用较小,AC5无显著贡献。AC6也是β-AR/PKA依赖性增强KATP电流的主要同工酶。KATP电流对静息膜电位和β-AR刺激引起的超极化至关重要。结论:AC6而非AC5,在血管平滑肌细胞血管舒张信号和膜电位调节中起主要作用,是血压控制中血管舒张装置的关键组分。
英文摘要
AIMS: Membrane potential is a key determinant of vascular tone and many vasodilators act through the modulation of ion channel currents [e.g. the ATP-sensitive potassium channel (K(ATP))] involved in setting the membrane potential. Adenylyl cyclase (AC) isoenzymes are potentially important intermediaries in such vasodilator signalling pathways. Vascular smooth muscle cells (VSMCs) express multiple AC isoenzymes, but the reason for such redundancy is unknown. We investigated which of these isoenzymes are involved in vasodilator signalling and regulation of vascular ion channels important in modulating membrane potential.
METHODS AND RESULTS: AC isoenzymes were selectively depleted (by >75%) by transfection of cultured VSMCs with selective short interfering RNA sequences. AC6 was the predominant isoenzyme involved in vasodilator-mediated cAMP accumulation in VSMCs, accounting for ∼60% of the total response to β-adrenoceptor (β-AR) stimulation. AC3 played a minor role in β-AR signalling, whereas AC5 made no significant contribution. AC6 was also the principal isoenzyme involved in β-AR-mediated protein kinase A (PKA) signalling (determined using the fluorescent biosensor for PKA activity, AKAR3) and the substantial β-AR/PKA-dependent enhancement of K(ATP) current. K(ATP) current was shown to play a vital role in setting the resting membrane potential and in mediating the hyperpolarization observed upon β-AR stimulation.
CONCLUSION: AC6, but not the closely related AC5, plays a principal role in vasodilator signalling and regulation of the membrane potential in VSMCs. These findings identify AC6 as a vital component in the vasodilatory apparatus central to the control of blood pressure.